US Patent Issued to Longeveron on Nov. 11 for "Method of treating aging frailty in subjects with inflammaging using human mesenchymal stem cells" (Florida Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,620, issued on Nov. 11, was assigned to Longeveron Inc. (Miami).

"Method of treating aging frailty in subjects with inflammaging using human mesenchymal stem cells" was invented by Joshua M. Hare (Miami) and Ana Marie Landin (Miami).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method of treating subjects with non-ischemic dilated cardiomyopathy by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells. The present invention also provides a method of treating subjects with symptoms of aging frailty by administering a therapeutically effective amount of an...